cladribine has been researched along with Acute Hemolytic Transfusion Reaction in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hoffman, PC | 1 |
Inoue, M; Kawa, K; Nakayama, M; Sawada, A; Yamada, K; Yasui, M | 1 |
1 review(s) available for cladribine and Acute Hemolytic Transfusion Reaction
Article | Year |
---|---|
Immune hemolytic anemia--selected topics.
Topics: Adrenal Cortex Hormones; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Blood Group Incompatibility; Cladribine; Combined Modality Therapy; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lymphocyte Subsets; Lymphoproliferative Disorders; Postoperative Complications; Rituximab; Splenectomy; Transfusion Reaction; Transplantation; Transplantation, Homologous; Venous Thromboembolism; Vidarabine | 2009 |
1 other study(ies) available for cladribine and Acute Hemolytic Transfusion Reaction
Article | Year |
---|---|
Severe persistent bone marrow failure following therapy with 2-chlorodeoxyadenosine for relapsing juvenile xanthogranuloma of the brain.
Topics: Anemia, Aplastic; Bone Marrow Diseases; Bone Marrow Failure Disorders; Bone Marrow Transplantation; Brain Diseases; Child; Cladribine; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Male; Prognosis; Recurrence; Transfusion Reaction; Xanthogranuloma, Juvenile | 2012 |